
The Hidden Weight of Type 1 Diabetes: What Young Adults Want Healthcare Teams to Understand
A new study reveals that young adults with Type 1 diabetes experience significant burden from their care routines and report moderate quality of life. The findings highlight where support is needed most.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Young adults with Type 1 diabetes report considerable treatment burden—the day-to-day effort and stress of managing their condition
- Emotional experiences and daily activities are the areas where quality of life is most affected
- Regular medical care appointments and reminders about diabetes are experienced as particularly burdensome
- Those with lower time in range (less stable blood sugar control) and dissatisfaction with their management approach report higher burden and lower quality of life
- The stronger the treatment burden, the lower the reported quality of life—suggesting these are closely linked challenges
Understanding the Real-World Impact of Type 1 Diabetes
Living with Type 1 diabetes involves much more than injections or pump changes. A new study published in Diabetic Medicine surveyed 294 young adults with Type 1 diabetes in the Netherlands to measure both the burden of treatment and their overall quality of life. The findings paint a picture of young people managing a condition that affects not just their physical health, but their emotional wellbeing and daily routines.
Using validated questionnaires, researchers measured treatment burden—the effort, stress, and hassle of managing diabetes—and health-related quality of life across emotional, social, and functional domains. The results show that young adults are carrying a considerable load.
What Creates the Most Burden?
Among all the demands of diabetes care, one factor stands out: regular medical appointments and the constant reminders that come with them. While these visits are essential for health monitoring, participants reported them as the most burdensome aspect of treatment. This suggests that even necessary care can feel overwhelming when it repeatedly highlights the presence of a chronic illness.
Overall, the average treatment burden score was 59.5 on a 0-150 scale, indicating a moderate-to-high level of burden across the group. This reflects the reality that Type 1 diabetes care extends far beyond the clinical setting into every aspect of daily life.
Where Quality of Life Suffers Most
When asked about quality of life, young adults reported scores that suggest their diabetes significantly impacts how they feel and function. The most affected area was emotional experiences and daily activities—the aspects of life that matter most to young people building their independence, relationships, and careers.
Young adults aged 18–25 reported lower quality of life scores than those aged 26–30, suggesting that the transition to adulthood—when independence and social life expand—may be a particularly challenging time. This pattern underscores the importance of age-appropriate support and understanding from healthcare providers.
The Connection Between Burden and Well-being
The study found a strong relationship between treatment burden and quality of life: the higher the burden, the lower the reported well-being. This connection wasn't surprising, but it was statistically significant, reinforcing what many people with Type 1 diabetes already know—that managing the disease takes an emotional and practical toll.
Certain factors made the burden worse: being female, having lower time in range (less stable blood sugar levels), and feeling dissatisfied with their current diabetes management approach were all associated with higher treatment burden and lower quality of life. This last point is particularly important: when young adults feel they have a management strategy that works for them, the burden decreases and their sense of well-being improves.
What This Means for Young Adults and Their Care Teams
This research validates what many young adults with Type 1 diabetes experience but may not always have language to express. The burden is real, and it matters. Healthcare providers who recognize treatment burden as a legitimate challenge—rather than something patients should simply accept—are better positioned to help.
The findings suggest that tailoring diabetes management to individual needs, ensuring access to technologies and approaches that work, and reducing unnecessary administrative friction in medical care could all help lower burden and improve quality of life. Young adults deserve care teams that understand not just their A1C numbers, but the emotional and practical weight of living with Type 1 diabetes.
Evidence label
Source: Diabetic medicine : a journal of the British Diabetic Association. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Cure & AdvancementsGene-Edited Islets Show Promise, But Long-Term Questions RemainPubMed indexed literature
- Cure & AdvancementsStem Cell-Derived Islets: A New Research Path Toward Restoring Insulin ProductionPubMed indexed literature
- Cure & AdvancementsBerberine Shows Promise for Pancreatic Cell Recovery in Type 1 Diabetes ResearchPubMed indexed literature
- Cure & AdvancementsNew Blood Test May Help Identify Type 1 Diabetes EarlierPubMed indexed literature
- Cure & AdvancementsNew Method Creates Better Insulin-Producing Cell Clusters for Transplant StudiesPubMed indexed literature
- Cure & AdvancementsA Vitamin A Compound Shows Promise in Rodent Models of Type 1 DiabetesPubMed indexed literature